Intuitive Investments Group PLC (IIG)

Category Sector Equity Healthcare

This investment trust can be held in an Investment ISA, SIPP and Investment Account

Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge. For those that show Ongoing charges as 0% please review the investment literature for details on the charges that will apply. The Financial Conduct Authority will review this in 2025.

If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.

Sell

110.00p

Buy

111.00p

arrow-down-8.00p (-6.78%)

Discount/Premium

-23.62%

Estimated NAV

154.50p

Prices updated at 24 Dec 2024, 12:30 GMT

Prices minimum 15 mins delay

Prices in GBX

Investment objective

To generate capital growth over the long term through investment in a portfolio concentrating on fast growing and/or high potential Life Sciences, Healthcare and Technology businesses operating predominantly in the UK, continental Europe, the US and APAC. The Company is targeting an average return to shareholders of 20% capital growth p.a.

FTSE All-Share

0.47%

LSE

Important documents: Please ensure that you have read the Key Information Document/Technical Guide , Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

Annual charges

Product charges
	-
	-
	0.00
Minimum investment	-

Documents

Document name chevron-l-regular chevron-r-regular	Language	Date posted
Semi-Annual Report	English	31 Mar 2024
Annual Report	English	30 Sep 2023

Please note that service charges will also apply. Read more about our fees.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.